Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.

Baraf HSB, Khanna PP, Petronijevic M, Lortkipanidze M, Patel A, Ayesu K, Pillinger MH, Singhal A, Sobierska J, Christie J, Traber P, Azeem R, DeHaan W, Santin-Janin H, Desai B, Kivitz A

Open source

DOI: 10.1002/art.70266
Published: 2026 Jun 25
Container: Arthritis & rheumatology (Hoboken, N.J.)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/art.70266,
  title = {Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.},
  author = {Baraf HSB and Khanna PP and Petronijevic M and Lortkipanidze M and Patel A and Ayesu K and Pillinger MH and Singhal A and Sobierska J and Christie J and Traber P and Azeem R and DeHaan W and Santin-Janin H and Desai B and Kivitz A},
  year = {2026},
  journal = {Arthritis \& rheumatology (Hoboken, N.J.)},
  doi = {10.1002/art.70266},
  url = {https://doi.org/10.1002/art.70266}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.
AU  - Baraf HSB
AU  - Khanna PP
AU  - Petronijevic M
AU  - Lortkipanidze M
AU  - Patel A
AU  - Ayesu K
AU  - Pillinger MH
AU  - Singhal A
AU  - Sobierska J
AU  - Christie J
AU  - Traber P
AU  - Azeem R
AU  - DeHaan W
AU  - Santin-Janin H
AU  - Desai B
AU  - Kivitz A
PY  - 2026
JO  - Arthritis & rheumatology (Hoboken, N.J.)
DO  - 10.1002/art.70266
UR  - https://doi.org/10.1002/art.70266
ER  -

APA

HSB, B., PP, K., M, P., M, L., A, P., K, A., MH, P., A, S., J, S., J, C., P, T., R, A., W, D., H, S., B, D., & A, K. (2026). Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.. Arthritis & rheumatology (Hoboken, N.J.). https://doi.org/10.1002/art.70266

Source records

pubmed · retrieved 2026-09-26T11:14:06.739Z